Across the globe, Cognate and Cobra are working to enable uninterrupted supply of cell and gene therapy products.

Dear Clients, Colleagues and Collaborators of Cognate and Cobra, In light of the evolving state of managing the COVID pandemic, Cognate and Cobra wanted to reassure our clients, and ultimately their patients, that we are an essential business, and having modified our schedules are working around the […]

Read more

WindMIL Therapeutics and Cognate BioServices Announce Agreement to Expand MILs Manufacturing Capacity

PHILADELPHIA, PA, BALTIMORE, MD and MEMPHIS, TN – March 10, 2020 – WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, and Cognate BioServices, Inc., a leading contract development and manufacturing organization (CDMO) in the global cellular therapies industry, today announced they have entered […]

Read more